Literature DB >> 25284705

Expression of hypoxia-inducible factor-1α and hepatocyte growth factor in development of fibrosis in the transplanted kidney.

Terese Kellenberger1, Niels Marcussen, Jens R Nyengaard, Lise Wogensen, Bente Jespersen.   

Abstract

Late renal graft loss is associated with interstitial fibrosis. Hypoxia-inducible factor-1α (HIF-1α) is thought to facilitate fibrosis through interaction with TGF-β1, while hepatocyte growth factor (HGF) may act antifibrotic in the kidney allograft. The aim of this study was to investigate the expression of HIF-1α and HGF in protocol biopsies as possible prognostic biomarkers for renal fibrosis. Thirty-nine renal transplant recipients were included in the study. Protocol biopsies performed 1 and 2 years after transplantation were used for immunohistochemistry analysis. The correlation between HIF-1α/HGF and the Banff score was analysed. In addition, progression in renal fibrosis and graft survival among recipients with high or low expression of HIF-1α/HGF after transplantation was compared. There was no significant correlation between fibrosis and the HIF-1α expression 1 and 2 years after transplantation, but an inverse significant correlation between the HGF expression and the fibrosis score 1 year after transplantation was shown. Even when adjusting for human leucocyte antigen mismatches, there was a significant relationship between fibrosis and HGF expression. Graft survival was not significantly correlated to HIF-1α or HGF at 1 year, although the trend was towards better graft survival with high HGF. HGF may have antifibrotic effects in human renal transplants. (Central.Denmark.Region.Committee number: 1-10-72-318-13).
© 2014 Steunstichting ESOT.

Entities:  

Keywords:  fibrosis; graft survival; hepatocyte growth factor; hypoxia-inducible factor-1α; renal transplantation

Mesh:

Substances:

Year:  2014        PMID: 25284705     DOI: 10.1111/tri.12475

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  TGF-β1 can be regulated by NDRG2 via the NF-κB pathway in hypoxia-induced liver fibrosis.

Authors:  Hong-Zhen Ba; Zhi-Hui Liang; Hyung Sik Kim; Wei Cao
Journal:  Ann Transl Med       Date:  2021-03

Review 2.  MMP-2 and 9 in Chronic Kidney Disease.

Authors:  Zhengyuan Cheng; Manoj Hang Limbu; Zhi Wang; Jing Liu; Lei Liu; Xiaoyi Zhang; Pingsheng Chen; Bicheng Liu
Journal:  Int J Mol Sci       Date:  2017-04-08       Impact factor: 5.923

3.  Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.

Authors:  Daniëlle G Leuning; Marlies E J Reinders; Joan Li; Anna J Peired; Ellen Lievers; Hetty C de Boer; Willem E Fibbe; Paola Romagnani; Cees van Kooten; Melissa H Little; Marten A Engelse; Ton J Rabelink
Journal:  Stem Cells Transl Med       Date:  2016-09-20       Impact factor: 6.940

4.  Antifibrotic Effects of Hepatocyte Growth Factor on Endothelial-to-Mesenchymal Transition via Transforming Growth Factor-Beta1 (TGF-β1)/Smad and Akt/mTOR/P70S6K Signaling Pathways.

Authors:  Zijie Wang; Shuang Fei; Chuanjian Suo; Zhijian Han; Jun Tao; Zhen Xu; Chunchun Zhao; Ruoyun Tan; Min Gu
Journal:  Ann Transplant       Date:  2018-01-02       Impact factor: 1.530

Review 5.  The "Sweet Spot" of Targeting Tumor Metabolism in Ovarian Cancers.

Authors:  Katelyn Tondo-Steele; Karen McLean
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

6.  The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment.

Authors:  Daniëlle G Leuning; Nick R M Beijer; Nadia A du Fossé; Steven Vermeulen; Ellen Lievers; Cees van Kooten; Ton J Rabelink; Jan de Boer
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.